Investigating new blood tests for diagnosing memory disorders

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the effectiveness of newly developed blood biomarkers for diagnosing memory-related conditions such as mild dementia and Alzheimer's disease. Conducted at the Memory Clinic of Skåne University Hospital in Malmö, it will involve 1200 patients who will provide blood and cerebrospinal fluid samples. The study will compare the diagnostic accuracy of blood tests against traditional cerebrospinal fluid tests to determine if blood tests can serve as a more cost-effective and patient-friendly alternative. The results will be assessed in a three-step process by the attending physician to gauge the impact on clinical decision-making.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Under investigation for cognitive symptoms at the Memory clinic.
2. Cerebrospinal fluid and blood sampling is planned to be done as part of clinical practice even if the patient is not taking part of this study.

Exclusion Criteria:

1. Not undergoing CSF or blood sampling as part of clinical practice.
2. Not undergoing cognitive testing as part of clinical practice.

Where it's running

• Skåne University Hospital
  Malmö, Sweden Recruiting

Study contacts

• Principal investigator: Erik Stomrud, MD, PhD — Skane University Hospital and Lund University
• Study coordinator: Erik Stomrud, MD, PhD
• Email: erik.stomrud@med.lu.se
• Phone: +46 40 33 10 00

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Improving early diagnosis of dementia in primary care

  This study is trying to find better ways to diagnose Alzheimer's and other memory problems early in people visiting their primary care doctors.

  Recruiting Skane University Hospital · Malmö · NCT06120361

• Using brain stimulation and digital training to improve cognitive function in older adults

  This study is testing whether a combination of brain stimulation and digital training can help improve thinking skills in older adults with Mild Cognitive Impairment and Alzheimer's Disease.

  Recruiting Universidade Federal do Rio de Janeiro · Rio de Janeiro, Rio de Janeiro · NCT06733714

• A study on early diagnosis and biomarkers for dementia and related diseases

  This study is testing new ways to spot dementia and related diseases early by looking for specific markers in the brain and body, to help people at high risk and track how well new treatments are working.

  Recruiting at 2 sites Skane University Hospital · Ängelholm and 1 other locations · NCT03174938

• Hyperspectral retinal imaging to detect Alzheimer’s and other neurodegenerative changes

  This project will test whether a special retinal camera that scans many wavelengths of light can detect signs of Alzheimer’s and other neurodegenerative diseases in people with dementia or at risk.

  Recruiting Center for Eye Research Australia · Melbourne, Victoria · NCT07545473

• Predicting disease progression in dementia using biomarkers and modeling

  This study is trying to create a tool that helps predict how dementia will progress in people with mild cognitive impairment and different types of dementia, like Alzheimer's and Lewy Body Disease, by looking at brain scans, body fluids, and mental tests.

  Recruiting University Health Network, Toronto · North York, Ontario and 3 other locations · NCT06529744

• Effects of social isolation and interaction on dementia risk in people with subjective cognitive decline

  This study is trying to see how being socially isolated or interacting with others affects the risk of dementia in people who notice early signs of memory problems.

  Recruiting The First Affiliated Hospital with Nanjing Medical University · Nanjing, China, Jiangsu · NCT06335836

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.